@article{c42711d6859643c4b7736e6c427ce3a9,
title = "Disparities in the quality of HIV care when using US department of health and human services indicators",
abstract = "We estimated US Department of Health and Human Services (DHHS)-approved human immunodeficiency virus (HIV) indicators. Among patients, 71% were retained in care, 82% were prescribed treatment, and 78% had HIV RNA ≤200 copies/mL; younger adults, women, blacks, and injection drug users had poorer outcomes. Interventions are needed to reduce retention- and treatment-related disparities.",
keywords = "HIV, HIV RNA suppression, antiretroviral therapy, quality of care, retention in care",
author = "Althoff, {Keri N.} and Peter Rebeiro and Brooks, {John T.} and Kate Buchacz and Kelly Gebo and Martin, {Jeffrey N.} and Hogg, {Robert S.} and Thorne, {Jennifer E.} and Klein, {Marina B.} and Gill, {M. John} and Sterling, {Timothy R.} and Baligh Yehia and Silverberg, {Michael J.} and Crane, {Heidi M.} and Justice, {Amy C.} and Gange, {Stephen J.} and Richard Moore and Kitahata, {Mari M.} and Horberg, {Michael A.} and Kirk, {Gregory D.} and Benson, {Constance A.} and Bosch, {Ronald J.} and Collier, {Ann C.} and Stephen Boswell and Chris Grasso and Mayer, {Kenneth H.} and {Richard Harrigan}, P. and Montaner, {Julio Sg} and Angela Cescon and Hasina Samji and Carey, {John T.} and Goedert, {James J.} and Jacobson, {Lisa P.} and Rourke, {Sean B.} and Burchell, {Ann N.} and Rachlis, {Anita R.} and Hunter-Mellado, {Robert F.} and Mayor, {Angel M.} and Deeks, {Steven G.} and Saag, {Michael S.} and Mugavero, {Michael J.} and James Willig and Eron, {Joseph J.} and Sonia Napravnik and Robert Dubrow and David Fiellin and David Haas and Sally Bebawy and Megan Turner and Kathryn Anastos and McKaig, {Rosemary G.} and Freeman, {Aimee M.} and Carol Lent and {Van Rompaey}, {Stephen E.} and Liz Morton and Justin McReynolds and Lober, {William B.} and Abraham, {Alison G.} and Bryan Lau and Jinbing Zhang and Jerry Jing and Elizabeth Golub and Shari Modur and Hanna, {David B.} and Cherise Wong and Adell Mendes",
note = "Funding Information: Financial support. This work was supported by grants U01-AI069918, U01-AA013566, U24-AA020794, U01-AA020790, U01-AI31834, U01-AI34989, U01-AI34993, U01-AI34994, U01-AI35004, U01-AI35039, U01-AI35040, U01-AI35041, U01-AI35042, U01-AI35043, U01-AI37613, U01-AI37984, U01-AI38855, U01-AI38858, U01-AI42590, U01-AI68634, U01-AI68636, U01-AI69432, U01-AI69434, U01-HD32632, U10-EY08057, U10-EY08052, U10-EY08067, UL1-RR024131, UL1-TR000083, U54-MD007587, F31-DA035713 (P. R.), G12-MD007583, K01-AI071754 (B. R. L.), K01-AI093197 (K. N. A.), K23 EY013707, K24-AI065298, K24-00432, MO1-RR-00052, N02-CP55504, P30-AI027763, P30-AI094189, P30-AI27757, P30-AI27767, P30-AI50410, P30-AI54999, P30-AI036219, P30-MH62246, R01-CA165937, R01-AA16893, R01-DA11602, R01-DA04334, R01-DA12568, R24-AI067039, R56-AI102622, Z01-CP010214, and Z01-CP010176 from the National Institutes of Health, USA; contract CDC200-2006-18797 from the Centers for Disease Control and Prevention, USA; contract 90047713 from the Agency for Healthcare Research and Quality, USA; contract 90051652 from the Health Resources and Services Administration, USA; grants TGF-96118, HCP-97105, CBR-86906, and CBR-94036 from the Canadian Institutes of Health Research, Canada; Ontario Ministry of Health and Long Term Care; and the Government of Alberta, Canada. The funding sources did not influence the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation; review; or approval of the manuscript or the decision to submit the manuscript for publication, with the exception of the Centers for Disease Control and Prevention, which did review the manuscript and provide optional feedback prior to submission. Funding Information: Potential conflicts of interest. K. G. reports grants from Tibotec, personal fees from Bristol Myers Squibb (BMS), and grants from the federal government outside the submitted work. M. K. reports grants from the Canadian Institute of Health Research (CIHR), Fonds de recherches en sant{\'e} du Qu{\'e}bec, and CIHR Canadian HIV Trials Network; personal fees from Glaxo-SmithKline/Viiv, BMS, and Gilead; and personal fees for travel/accommodations/meeting expenses unrelated to activities listed outside the submitted work. M. J. S. reports grants from Pfizer and Merck outside the submitted work. J. E. T. reports grants from the federal government during the conduct of the study; grants and other from AbbVie; grants and personal fees from XOMA; personal fees from Gilead, Navigent, and Santen; and grants from Allergan, Inc., outside the submitted work.",
year = "2014",
month = apr,
day = "15",
doi = "10.1093/cid/ciu044",
language = "English (US)",
volume = "58",
pages = "1185--1189",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "8",
}
